vs
Side-by-side financial comparison of ImmunityBio, Inc. (IBRX) and LCNB CORP (LCNB). Click either name above to swap in a different company.
ImmunityBio, Inc. is the larger business by last-quarter revenue ($38.3M vs $23.9M, roughly 1.6× LCNB CORP). LCNB CORP runs the higher net margin — 23.7% vs -161.8%, a 185.5% gap on every dollar of revenue. On growth, ImmunityBio, Inc. posted the faster year-over-year revenue change (407.0% vs 5.1%). LCNB CORP produced more free cash flow last quarter ($33.4M vs $-71.3M).
ImmunityBio, Inc. is a clinical-stage biotechnology company focused on developing next-generation immunotherapies and vaccine candidates targeting multiple cancer types and infectious diseases. It operates mainly in the U.S. market, with core R&D segments including cell therapy, antibody therapeutics, and targeted vaccine platforms designed to enhance patient treatment outcomes.
LCNB Corp is a United States-based financial holding company that operates through its national bank subsidiary, providing a full suite of retail and commercial banking products and services including deposit accounts, various loan products, wealth management, and insurance solutions primarily to individual consumers, small and medium-sized enterprises and local community organizations across regional markets in Ohio.
IBRX vs LCNB — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $38.3M | $23.9M |
| Net Profit | $-61.9M | $5.7M |
| Gross Margin | 99.0% | — |
| Operating Margin | -169.0% | 29.2% |
| Net Margin | -161.8% | 23.7% |
| Revenue YoY | 407.0% | 5.1% |
| Net Profit YoY | -4.7% | -7.6% |
| EPS (diluted) | $-0.06 | $0.40 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $38.3M | $23.9M | ||
| Q3 25 | $32.1M | $23.8M | ||
| Q2 25 | $26.4M | $22.8M | ||
| Q1 25 | $16.5M | $21.5M | ||
| Q4 24 | $7.6M | $22.7M | ||
| Q3 24 | $6.1M | $21.4M | ||
| Q2 24 | — | $19.3M | ||
| Q1 24 | — | $17.8M |
| Q4 25 | $-61.9M | $5.7M | ||
| Q3 25 | $-67.3M | $6.9M | ||
| Q2 25 | $-92.6M | $5.9M | ||
| Q1 25 | $-129.6M | $4.6M | ||
| Q4 24 | $-59.2M | $6.1M | ||
| Q3 24 | $-85.7M | $4.5M | ||
| Q2 24 | — | $925.0K | ||
| Q1 24 | — | $1.9M |
| Q4 25 | 99.0% | — | ||
| Q3 25 | 99.4% | — | ||
| Q2 25 | 99.5% | — | ||
| Q1 25 | 99.6% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | -169.0% | 29.2% | ||
| Q3 25 | -173.5% | 35.6% | ||
| Q2 25 | -269.8% | 31.6% | ||
| Q1 25 | -390.1% | 25.6% | ||
| Q4 24 | -919.0% | 32.9% | ||
| Q3 24 | -1314.3% | 24.9% | ||
| Q2 24 | — | 4.9% | ||
| Q1 24 | — | 12.5% |
| Q4 25 | -161.8% | 23.7% | ||
| Q3 25 | -209.8% | 29.1% | ||
| Q2 25 | -350.3% | 26.0% | ||
| Q1 25 | -784.9% | 21.4% | ||
| Q4 24 | -783.4% | 27.0% | ||
| Q3 24 | -1404.0% | 21.2% | ||
| Q2 24 | — | 4.8% | ||
| Q1 24 | — | 10.7% |
| Q4 25 | $-0.06 | $0.40 | ||
| Q3 25 | $-0.07 | $0.49 | ||
| Q2 25 | $-0.10 | $0.41 | ||
| Q1 25 | $-0.15 | $0.33 | ||
| Q4 24 | $-0.08 | $0.44 | ||
| Q3 24 | $-0.14 | $0.31 | ||
| Q2 24 | — | $0.07 | ||
| Q1 24 | — | $0.15 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $242.8M | $21.6M |
| Total DebtLower is stronger | — | $104.4M |
| Stockholders' EquityBook value | $-500.5M | $273.9M |
| Total Assets | $501.9M | $2.2B |
| Debt / EquityLower = less leverage | — | 0.38× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $242.8M | $21.6M | ||
| Q3 25 | $257.8M | $35.9M | ||
| Q2 25 | $153.7M | $49.8M | ||
| Q1 25 | $61.6M | $37.7M | ||
| Q4 24 | $149.8M | $35.7M | ||
| Q3 24 | $130.4M | $39.4M | ||
| Q2 24 | — | $34.9M | ||
| Q1 24 | — | $33.0M |
| Q4 25 | — | $104.4M | ||
| Q3 25 | — | $104.7M | ||
| Q2 25 | — | $105.0M | ||
| Q1 25 | — | $104.6M | ||
| Q4 24 | — | $155.2M | ||
| Q3 24 | — | $155.7M | ||
| Q2 24 | — | $162.2M | ||
| Q1 24 | — | $162.6M |
| Q4 25 | $-500.5M | $273.9M | ||
| Q3 25 | $-524.3M | $269.9M | ||
| Q2 25 | $-570.7M | $263.5M | ||
| Q1 25 | $-591.4M | $258.7M | ||
| Q4 24 | $-489.1M | $253.0M | ||
| Q3 24 | $-745.1M | $253.2M | ||
| Q2 24 | — | $245.2M | ||
| Q1 24 | — | $233.7M |
| Q4 25 | $501.9M | $2.2B | ||
| Q3 25 | $519.0M | $2.2B | ||
| Q2 25 | $402.1M | $2.3B | ||
| Q1 25 | $303.8M | $2.3B | ||
| Q4 24 | $382.9M | $2.3B | ||
| Q3 24 | $364.6M | $2.3B | ||
| Q2 24 | — | $2.4B | ||
| Q1 24 | — | $2.3B |
| Q4 25 | — | 0.38× | ||
| Q3 25 | — | 0.39× | ||
| Q2 25 | — | 0.40× | ||
| Q1 25 | — | 0.40× | ||
| Q4 24 | — | 0.61× | ||
| Q3 24 | — | 0.61× | ||
| Q2 24 | — | 0.66× | ||
| Q1 24 | — | 0.70× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-70.4M | $34.4M |
| Free Cash FlowOCF − Capex | $-71.3M | $33.4M |
| FCF MarginFCF / Revenue | -186.2% | 140.2% |
| Capex IntensityCapex / Revenue | 2.4% | 4.0% |
| Cash ConversionOCF / Net Profit | — | 6.08× |
| TTM Free Cash FlowTrailing 4 quarters | $-308.8M | $54.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-70.4M | $34.4M | ||
| Q3 25 | $-68.9M | $14.0M | ||
| Q2 25 | $-79.7M | $5.5M | ||
| Q1 25 | $-85.9M | $2.2M | ||
| Q4 24 | $-85.1M | $93.2M | ||
| Q3 24 | $-98.8M | $11.9M | ||
| Q2 24 | — | $54.9M | ||
| Q1 24 | — | $-11.9M |
| Q4 25 | $-71.3M | $33.4M | ||
| Q3 25 | $-69.6M | $13.7M | ||
| Q2 25 | $-80.8M | $5.2M | ||
| Q1 25 | $-87.0M | $2.1M | ||
| Q4 24 | $-87.3M | $89.4M | ||
| Q3 24 | $-101.6M | $10.5M | ||
| Q2 24 | — | $53.8M | ||
| Q1 24 | — | $-12.8M |
| Q4 25 | -186.2% | 140.2% | ||
| Q3 25 | -217.2% | 57.4% | ||
| Q2 25 | -305.9% | 23.0% | ||
| Q1 25 | -526.9% | 10.0% | ||
| Q4 24 | -1155.4% | 394.0% | ||
| Q3 24 | -1663.2% | 49.0% | ||
| Q2 24 | — | 278.6% | ||
| Q1 24 | — | -71.8% |
| Q4 25 | 2.4% | 4.0% | ||
| Q3 25 | 2.3% | 1.3% | ||
| Q2 25 | 4.1% | 1.0% | ||
| Q1 25 | 6.8% | 0.3% | ||
| Q4 24 | 28.0% | 16.7% | ||
| Q3 24 | 45.7% | 6.7% | ||
| Q2 24 | — | 5.9% | ||
| Q1 24 | — | 4.8% |
| Q4 25 | — | 6.08× | ||
| Q3 25 | — | 2.02× | ||
| Q2 25 | — | 0.92× | ||
| Q1 25 | — | 0.48× | ||
| Q4 24 | — | 15.23× | ||
| Q3 24 | — | 2.63× | ||
| Q2 24 | — | 59.35× | ||
| Q1 24 | — | -6.24× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
